Neurological damage from vitamin B12 deficiency can begin before a standard blood panel looks abnormal. The depletion sequence can unfold over years: stores quietly decline, then functional deficiency emerges with elevated methylmalonic acid and homocysteine, and only later does the number on a serum B12 report drop below the reference range.1 By the time a routine test flags something, irreversible nerve damage may already be underway.
That delay matters most for the populations with the highest deficiency risk: people eating exclusively or mostly plant-based, adults over fifty whose gastric function has changed, people taking metformin or GLP-1 medications, and post-bariatric patients. Each of these groups has a structural reason why the usual "check B12 annually" approach is insufficient without understanding what to check and what to take.
01The four-stage depletion sequence
Victor Herbert's staging model, published in 1994, describes how B12 status declines before clinical signs appear.1 The model was built on vegetarian populations but applies to any prolonged deficiency.
| Stage | What is happening | Serum B12 | Holotranscobalamin | MMA / Homocysteine | Clinical signs |
|---|---|---|---|---|---|
| 1 | Hepatic stores depleting, intake insufficient | Normal to low-normal | Falling | Normal | None |
| 2 | Serum B12 falling, active fraction dropping | Low-normal to low | Low | Borderline rising | None |
| 3 | Functional deficiency, impaired methylation and DNA synthesis | Low | Low | Elevated | Possible fatigue, cognitive fog |
| 4 | Macrocytic anemia or neurological symptoms | Low or very low | Low | Elevated | Anemia, neuropathy, subacute combined degeneration |
A routine serum B12 catches stages 3 and 4. Stages 1 and 2 are the window where intervention is most effective and least complicated. Most screening misses them.
The neurological risk carries a specific caveat. Subacute combined degeneration of the spinal cord, the most severe form of B12-related nerve damage, can appear before macrocytic anemia develops, particularly in people supplementing folic acid. Folate repletes the blood picture without addressing the neurological pathway, which creates the appearance of recovery while the nerve damage continues.2
02Why supplement dose math is different for plant-based eaters
B12 absorption depends on dose size, food matrix, and gastric function. Understanding those pieces explains why supplement dosing for vegans looks different from the standard advice for omnivores.
Intrinsic factor-mediated absorption is the primary route. Gastric parietal cells secrete intrinsic factor, which binds B12 in the small intestine and carries it through a specific receptor in the terminal ileum. This pathway is efficient but has a hard ceiling: it saturates at approximately 1 to 2 mcg per dose or meal, regardless of how much B12 is present.3 For an omnivore eating meat, fish, and eggs across three meals, this pathway can reliably deliver the 2.4 mcg daily requirement without any supplement.
Free supplemental B12 does not need to be released from food protein by stomach acid and gastric enzymes. It can still use intrinsic-factor transport at lower doses, then relies increasingly on passive diffusion as the dose rises.9 Passive diffusion requires no intrinsic factor and works proportionally to dose: approximately 1 percent of a large oral dose crosses the gut wall by diffusion.3 Plant-based eaters can use frequent fortified foods, a daily supplement, or a larger weekly supplement.
| Strategy | Why it works | Best fit |
|---|---|---|
| Fortified foods multiple times per day | Smaller B12 exposures can use active absorption more efficiently. | People who already eat fortified cereal, milk, or yeast |
| 50 mcg cyanocobalamin daily | A 12-week trial in vegans and vegetarians with marginal status found this dose improved metabolic markers. | Daily supplement users |
| 2,000 mcg cyanocobalamin weekly | Larger weekly dosing relies more on passive diffusion and also improved markers in the same trial. | People who remember a weekly reminder better |
The RDA is 2.4 mcg per day for adults, but maintenance planning for plant-based diets needs a reliable source because unfortified plant foods do not naturally provide B12.9 In a randomized trial of vegans and vegetarians with marginal B12 status, 50 mcg per day and 2,000 mcg per week both improved B12 markers over 12 weeks.10
The practical decision is adherence. Use 50 mcg daily if a daily habit is easy. Use 2,000 mcg weekly if a weekly reminder is more reliable. Higher oral doses belong in repletion plans, malabsorption cases, or clinician-directed treatment rather than routine maintenance.
03Who needs to pay close attention
| Population | Why B12 absorption is compromised | Recommended action |
|---|---|---|
| Strict vegans | No reliable unfortified plant-food B12 source. Fortified foods or supplements are required. | 50 mcg daily or 2,000 mcg weekly |
| Vegetarians with low dairy and egg intake | Dairy and eggs can contribute B12, but intake often varies enough to require confirmation. | Supplement or confirm actual daily dairy and egg B12 from food logs |
| Adults over 50 | Gastric acid and intrinsic factor production can decline with age. Food-bound B12 absorption becomes less reliable. | Get most B12 from fortified foods or supplements.11 |
| Metformin users | Metformin increases B12 deficiency risk during long-term use. | Periodic B12 + MMA monitoring. Supplement if borderline or low.5 |
| GLP-1 medication users | Lower intake, reflux treatment, and reduced tolerance for animal-source foods can narrow B12 intake. | Annual monitoring. Supplement if borderline or low. |
| Post-bariatric patients | Gastric resection reduces intrinsic factor production significantly. | Medical supervision. Often requires injection or very high oral doses. |
| Chronic PPI users | Acid suppression impairs food-bound B12 release from food matrix. | Annual monitoring. Supplement with 500 mcg daily if taking PPIs long-term.6 |
Adults over fifty deserve particular attention. Atrophic gastritis becomes more common with age and can reduce gastric acid and intrinsic factor production. The practical consequence: food-bound B12 from meat and dairy becomes less reliable even as free supplemental B12 remains available because it does not require pepsin-mediated release from food protein.4 This is why older adults can have adequate B12 from food sources for decades and then develop deficiency after fifty without changing their diet at all.
04What to ask for when testing
Serum B12 is a reasonable starting point but a poor solo test for anyone at risk. Two additional markers add much more information.
Holotranscobalamin (holoTC) is the fraction of serum B12 bound to transcobalamin II, which is the form cells can actually absorb and use. Approximately 20 to 25 percent of total serum B12 is holoTC. It is the earliest-declining marker in the depletion sequence and begins falling in stage 1, before serum B12 looks abnormal. For plant-based eaters, requesting holoTC alongside serum B12 gives a cleaner read on whether cellular B12 supply is actually adequate.7
Methylmalonic acid (MMA) is the most specific functional marker for B12 status. When cellular B12 is insufficient, the methylmalonyl-CoA mutase reaction backs up and MMA accumulates in blood and urine. Elevated MMA confirms functional deficiency even when serum B12 is technically in range. It is the test that catches stage 2 and early stage 3 before macrocytic anemia develops.
Homocysteine rises with B12 deficiency through a different pathway: impaired conversion of homocysteine to methionine when the 5-methyltetrahydrofolate-homocysteine methyltransferase reaction falters. Elevated homocysteine is a sensitive but less specific marker for B12 deficiency because folate and B6 deficiencies cause the same pattern.
| Marker | What it measures | When it becomes abnormal | Best for |
|---|---|---|---|
| Serum B12 | Total circulating B12 (all forms) | Stages 3–4 | Confirming overt deficiency |
| Holotranscobalamin | Bioavailable fraction only | Stage 1–2 | Early detection in plant-based eaters |
| Methylmalonic acid (MMA) | Functional B12 at the cellular level | Stage 2–3 | Most specific: confirms true functional deficiency |
| Homocysteine | Methylation capacity (B12, folate, B6) | Stage 2–3 | Sensitive but not specific for B12 alone |
The practical request for a plant-based eater or older adult is serum B12 plus MMA. NIH ODS notes that serum MMA can help confirm B12 deficiency when serum B12 is in an indeterminate range.9 If serum B12 is low-normal and MMA is elevated, status should be treated as functionally inadequate rather than dismissed as normal.
05Supplement forms and protocols
| Form | Notes | Best use case |
|---|---|---|
| Cyanocobalamin | Synthetic, most stable, cheapest, well-studied. Converted to active forms in vivo. | Default for most people. What most trials use. |
| Methylcobalamin | Active coenzyme form. More expensive. Marketed as superior but head-to-head data is thin. | Reasonable alternative. Preferred by some with MTHFR concerns. |
| Hydroxocobalamin | Longer half-life, used primarily in injection protocols | Useful for clinical repletion when injections are indicated |
| Adenosylcobalamin | Mitochondrial active form. Rarely used alone. | Sometimes combined with methylcobalamin in "complete B12" products |
Both cyanocobalamin and methylcobalamin raise B12 status effectively in trials. The cyanocobalamin-versus-methylcobalamin debate is largely a marketing distinction. Cyanocobalamin is the form used in the vast majority of clinical research and performs well in them.
Dosing by population:
| Population | Maintenance protocol | When to escalate |
|---|---|---|
| Vegan adult, healthy absorption | 50 mcg daily or 2,000 mcg weekly10 | If serum B12, MMA, or symptoms suggest deficiency |
| Vegetarian with low dairy and egg intake | 50 mcg daily if fortified foods are inconsistent10 | If labs remain borderline after consistent intake |
| Adult over 50 | Fortified foods or supplements as the main B12 source11 | If food-bound malabsorption or low markers are present |
| Metformin or GLP-1 user | Lab-directed supplementation5 | If serum B12 plus MMA are borderline or low |
| Confirmed clinical deficiency | Medical supervision | Severe anemia, neurological signs, or malabsorption |
06Food sources and their honest limits
Food-composition data show clearly where B12 concentrates and where plant-based sources fall short.12
| Source | B12 per 100 g or serving | Notes |
|---|---|---|
| Beef liver | ~70 mcg | Exceptional density, but not a daily food for most people |
| Clams (cooked) | ~98 mcg | Highest common food source per gram |
| Salmon (cooked) | ~3.2 mcg | One 150 g serving covers roughly two days of RDA |
| Beef (lean, cooked) | ~2.0–2.5 mcg | Reliable but not concentrated |
| Egg | Meaningful but modest per egg12 | Useful contributor for vegetarians, not a reliable sole B12 plan |
| Whole milk | Low per standard serving | Useful as a contributor, not a reliable sole B12 plan |
| Fortified nutritional yeast | ~1–8 mcg per tablespoon | Only if fortified. Content varies widely by brand. Check the label. |
| Spirulina | Contains pseudocobalamin analogs | Not a reliable source.8 |
| Nori (dried) | Variable, some true B12 present | Highly variable. Content unreliable across batches and processing. |
| Tempeh, miso, sauerkraut | Not a meaningful source | Bacterial contamination can produce trace B12 analogs, not true B12 |
The spirulina point deserves emphasis because it circulates confidently in plant-based communities. Spirulina predominantly contains pseudovitamin B12 and is not a reliable source. Characterization work on edible algae found that common algae sources can contain inactive B12 analogs rather than reliable active cobalamin.8 The same caution applies to most dried algae except for specific nori-based preparations, and even those are unreliable for regular B12 supply.
07Where testing meets supplementation
The most common pattern in plant-based eaters with early deficiency: serum B12 in the low-normal range, MMA mildly elevated, no symptoms. This is staging 2. The right response is to start reliable supplementation and follow the same marker pair over time.
What usually happens instead: the serum B12 comes back "normal," the person is told to eat more fortified foods, and they continue relying on nutritional yeast that may or may not be fortified. The stores continue declining toward stages 3 and 4.
Vitamin D for athletes and iron repletion for endurance athletes share the same core structure: both nutrients have absorption mechanisms that make naive dosing ineffective, both require testing the right marker to catch deficiency before it becomes costly, and both are easy to correct once the mechanism is understood. B12 follows the same pattern. The serum number moves late in the depletion sequence.
For practical diet planning alongside B12 management, the plant-based protein guide covers the other micronutrient gaps that accompany full plant-based eating, and the B vitamins glossary provides the full coenzyme context for the B12-adjacent nutrients.
Footnotes
Herbert V. Staging vitamin B-12 (cobalamin) status in vegetarians. Am J Clin Nutr. 1994. 59(5 Suppl):1213S-1222S. PubMed
↩Stabler SP. Clinical practice. Vitamin B12 deficiency. N Engl J Med. 2013. 368(2):149-160. PubMed
↩Green R, Allen LH, Bjørke-Monsen AL, et al. Vitamin B12 deficiency. Nat Rev Dis Primers. 2017. 3:17040. PubMed
↩Baik HW, Russell RM. Vitamin B12 deficiency in the elderly. Annu Rev Nutr. 1999. 19:357-377. PubMed
↩de Jager J, Kooy A, Lehert P, et al. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. BMJ. 2010. 340:c2181. PubMed
↩Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013. 310(22):2435-2442. PubMed
↩Nexo E, Hoffmann-Lücke E. Holotranscobalamin, a marker of vitamin B-12 status: analytical aspects and clinical utility. Am J Clin Nutr. 2011. 94(1):359S-365S. PubMed
↩Watanabe F, Takenaka S, Katsura H, et al. Characterization and bioavailability of vitamin B12-compounds from edible algae. J Nutr Sci Vitaminol (Tokyo). 2002. 48(5):325-331. PubMed
↩National Institutes of Health Office of Dietary Supplements. Vitamin B12 Fact Sheet for Health Professionals. NIH ODS
↩Del Bo' C, Riso P, Gardana C, et al. Effect of two different sublingual dosages of vitamin B12 on cobalamin nutritional status in vegans and vegetarians with a marginal deficiency: a randomized controlled trial. Clin Nutr. 2019. 38(2):575-583. PubMed
↩Linus Pauling Institute. Vitamin B12. Oregon State University. LPI
↩USDA FoodData Central. Vitamin B12 food composition data. USDA FDC
↩
